Drug Shortage Report for ANTITHROMBIN III NF
Report ID | 128404 |
Drug Identification Number | 02237810 |
Brand name | ANTITHROMBIN III NF |
Common or Proper name | Antithrombin III (human) |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ANTITHROMBIN III |
Strength(s) | 1100UNIT |
Dosage form(s) | KIT POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 20 mL |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-11-13 |
Actual start date | 2020-11-13 |
Estimated end date | 2020-12-15 |
Actual end date | 2020-12-01 |
Shortage status | Resolved |
Updated date | 2020-12-02 |
Company comments | Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-12-02 | English | Compare |
v4 | 2020-12-02 | French | Compare |
v3 | 2020-12-02 | English | Compare |
v2 | 2020-11-13 | French | Compare |
v1 | 2020-11-13 | English | Compare |
Showing 1 to 5 of 5